Thioredoxin in coronary culprit lesions: possible relationship to oxidative stress and intraplaque hemorrhage

Kensaku Nishihira1, Atsushi Yamashita, Takuroh Imamura

  • 1Division of Circulatory and Body Fluid Regulation, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan.

Atherosclerosis
|April 19, 2008
PubMed

Insights

Thioredoxin (TRX), an antioxidant protein, is elevated in unstable angina pectoris (UAP) patients, correlating with plaque instability markers like hemorrhage and thrombus formation. This suggests TRX may indicate vulnerable coronary lesions.

Area of Science:

  • Cardiovascular Biology
  • Oxidative Stress Research
  • Atherosclerosis Pathogenesis

Background:

  • Thioredoxin (TRX) is a key antioxidant protein.
  • Atherosclerotic plaque instability is a major cause of acute coronary syndromes.
  • Oxidative stress plays a critical role in atherosclerosis.

Purpose of the Study:

  • To investigate thioredoxin (TRX) expression in stable (SAP) versus unstable angina pectoris (UAP) patients.
  • To determine the relationship between TRX and markers of plaque instability in coronary atherectomy specimens.
  • To explore the association of TRX with oxidized low-density lipoprotein (ox-LDL), hemorrhage, and iron deposition.

Main Methods:

  • Histological assessment of atherectomy specimens from SAP and UAP patients.
  • Immunohistochemical analysis for macrophage, TRX, oxidized low-density lipoprotein (ox-LDL), and glycophorin A (intraplaque hemorrhage).
  • Assessment of transition metal iron (Fe(2+), Fe(3+)) deposition.

Main Results:

  • TRX, macrophage, and ox-LDL expression were significantly higher in UAP patients compared to SAP patients.
  • Intraplaque hemorrhage and iron deposition were more pronounced in UAP lesions.
  • TRX and ox-LDL positively correlated with iron deposition and thrombus formation.

Conclusions:

  • TRX is upregulated in unstable coronary artery lesions, likely due to increased oxidative stress.
  • TRX expression is associated with intraplaque hemorrhage and thrombus formation.
  • TRX may serve as a valuable biomarker for coronary plaque instability.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...